About Aquigen Bio
Aquigen Bio is a company based in Pune (India) founded in 2018. It operates as a B2B. The company has 1 employees as of March 31, 2024. Aquigen Bio offers products and services including API Impurities, Deuterated Labelled Compound, Peptide Impurity Standards, API and Intermediates, and Analytical Services. Aquigen Bio operates in a competitive market with competitors including Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
- Headquarter Pune, India
- Employees 1 as on 31 Mar, 2024
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Aquigen Bio Science Private Limited
- Date of Incorporation 26 Apr, 2018
- Jurisdiction Mulshi, Maharashtra, India
-
Annual Revenue
$1.57 M (USD)33.2as on Mar 31, 2024
-
Net Profit
$234.06 K (USD)49.58as on Mar 31, 2024
-
EBITDA
$360.64 K (USD)70.27as on Mar 31, 2024
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
1
as on Mar 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Aquigen Bio
Aquigen Bio offers a comprehensive portfolio of products and services, including API Impurities, Deuterated Labelled Compound, Peptide Impurity Standards, API and Intermediates, and Analytical Services.
Standards for testing pharmaceutical impurities in drug development.
Compounds for metabolism and pharmacokinetic studies in pharmaceuticals.
Standards for ensuring purity in peptide-based drug development.
Custom synthesis of drug ingredients and intermediates for research.
Services for impurity isolation and characterization in pharmaceuticals.
Funding Insights of Aquigen Bio
Detailed funding history for Aquigen Bio
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Aquigen Bio
Investment portfolio details for Aquigen Bio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Aquigen Bio
Detailed financials for Aquigen Bio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Aquigen Bio Comparisons
Peer comparison for Aquigen Bio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Aquigen Bio
Aquigen Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical and biotechnology company
|
|
| Locked | Locked | Locked |
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
|
|
| Locked | Locked | Locked |
APIs and drug products are developed and valorized in pharmaceuticals.
|
|
| Locked | Locked | Locked |
APIs, intermediates, and biochemical reagents are developed and manufactured.
|
|
| Locked | Locked | Locked |
APIs are developed and manufactured for therapeutic areas.
|
|
| Locked | Locked | Locked |
Contract development, manufacturing, and analytical services for APIs are offered.
|
Detailed competitors of Aquigen Bio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Aquigen Bio
Complete news archive for Aquigen Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aquigen Bio
Aquigen Bio was founded in 2018.
Aquigen Bio is headquartered in Pune, India. It is registered at Pune, Maharashtra, India.
As of Mar 31, 2024, the latest employee count at Aquigen Bio is 1.
Annual revenue of Aquigen Bio is $1.57M as on Mar 31, 2024.
Aquigen Bio Sciences specializes in manufacturing and supplying pharmaceutical impurity standards, deuterated labelled compounds, and peptide impurity standards. They offer custom synthesis projects for APIs, intermediates, and analytical services like impurity isolation and characterization. Based primarily in Pune, India, with additional locations in the USA and Brazil, they support global researchers and pharmaceutical companies in drug development and testing.
Aquigen Bio's top competitors include Laurus Labs, Symbiotec and Beijing Biostar Technologies.
Aquigen Bio offers API Impurities, Deuterated Labelled Compound, Peptide Impurity Standards, API and Intermediates, and Analytical Services.